Global Biodegradable Stents Markets, 2018-2019 & 2023 - R&D Issues, Global Regulatory Scenarios and Commercialization Hurdles

News provided by

May 03, 2019, 07:15 ET

DUBLIN, May 3, 2019 /PRNewswire/ -- The "Biodegradable Stents: Global Markets" report has been added to ResearchAndMarkets.com's offering.

This report reviews both global and regional markets of the biodegradable stents market according to available types and application areas. The report analyzes the current market status and trends, and provides growth forecasts for the five-year period 2018 to 2023.

The analysis also discusses R&D issues, including global regulatory scenarios and other commercialization hurdles. Additionally, this comprehensive report examines technology developers/manufacturers of biodegradable stents, their product types and geographical product presence (wherever data is available).

The biodegradable stents market is divided into the following types

Polymer-based.
Metal-based.

The report differentiates BDS from conventional metallic DES that have a matrix coating of bioresorbable polymer and antiproliferative drug. These devices, which have typical metallic nondegradable stent backbones, are known as bioresorbable polymer DES, bioabsorbable polymer DES or biodegradable polymer DES. Therefore, this report concentrates only on the BDS market for fully bioabsorbable or biodegradable stents.

The applications of the biodegradable stent market that have been analyzed in this report includes

BDS for vascular disease.
Coronary BDS.
Non-coronary vascular BDS.
BDS for non-vascular disease.
Ureteral.
Gastrointestinal.
Biliary.
Pancreatic.
Others.

The report also offers a detailed patent analysis with information on the strategic initiatives of market players within the past five years.

The report specifically excludes stents that are not fully biodegradable and also stents that have bioabsorbable coatings which are not fully bioabsorbable. The report also excludes biomaterial technology/product and equipment providers.

Estimated values used are based on manufacturers' total revenues. Projected and forecasted revenue values are in constant U.S. dollars, unadjusted for inflation.

Key Topics Covered:

Chapter 1 Introduction

Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Methodology and Information Sources
Geographic Breakdown
Analyst's Credentials
Custom Research
Related Reports

Chapter 2 Summary and Highlights

Chapter 3 Market and Technology Background

Technology Overview
Unmet Needs of Current Metallic DES
Very Late Stent Thrombosis and Restenosis
Implications of the Removal of a Permanent Implant
Technology Background
Technological Advantages of Biodegradable Stents
Technological Disadvantages
BDS Material Platform and Classification
Polymeric Biodegradable Stents
Metallic Biodegradable Stents
Market Regulation
Key Drivers
Growing Cardiovascular Intervention Market
Aging Populations
Emerging Middle Class
Increased Health Awareness
Key Challenges
Regulatory Issues
High Cost of Products/Procedure
Safety Issues
Visualization of the Scaffold for Implantation
Scaffold Deliverability
Scaffold Implantation
Radial Strength
Low Ductility
Market Trends

Chapter 4 Market Breakdown by Application Type

Biodegradable Vascular Stents (BVS)
Biodegradable Stents for Coronary Disease
Biodegradable Stents for Non-coronary Vascular Disease
BDS for Non-vascular Disease
Ureteral Stents
Gastrointestinal Stents
Bile Duct/Pancreatic Stents
Tracheobronchial/Pulmonary Stents

Chapter 5 Market Breakdown by Region

North America
U.S.
APAC
India
China
European Union
ROW
Brazil

Chapter 6 Patent Review

Patent Review by Year
Patent Review by Country
Patent Review by Assignee
Patent Review by Application

Chapter 7 Company Profiles

Abbott Vascular Inc.
Akina Inc.
Amaranth Medical Inc.
AMG International Gmbh
Arterial Remodeling Technologies S.A. (Art)
Arterius Ltd.
Biotronik Inc.
Boston Scientific Corp.
Cardionovum Gmbh
Elixir Medical Corp.
Ella-Cs S.R.O.
Endocor Gmbh
Hydrustent
Kyoto Medical Planning Co. Ltd.
Lepu Medical Technology (Beijing) Co. Ltd.
Lifetech Scientific Corp.
Lyra Therapeutics
Meril Life Sciences
Micell Technologies Inc.
Microport Scientific Corp.
Reva Medical Inc.
S3V Vascular Technologies
Sahajanand Medical Technologies (Smt)
Sino Medical Sciences Technology Inc. (Sinomed)
Stentys S.A.
Tepha Inc.
Terumo Cardiovascular Systems Corp.
Zorion Medical Inc.

Chapter 8 Appendix

For more information about this report visit https://www.researchandmarkets.com/r/opx0hc

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets